76 related articles for article (PubMed ID: 11020511)
1. Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.
Anawalt BD; Herbst KL; Matsumoto AM; Mulders TM; Coelingh-Bennink HJ; Bremner WJ
Fertil Steril; 2000 Oct; 74(4):707-14. PubMed ID: 11020511
[TBL] [Abstract][Full Text] [Related]
2. Male contraception development: monitoring effective spermatogenesis suppression utilizing a user-controlled sperm concentration test compared with standard semen analysis.
Lue Y; Swerdloff R; Pak Y; Nguyen BT; Yuen F; Liu PY; Blithe DL; Wang C
Fertil Steril; 2023 Feb; 119(2):208-217. PubMed ID: 36347310
[TBL] [Abstract][Full Text] [Related]
3. Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis.
Liu PY; Swerdloff RS; Anawalt BD; Anderson RA; Bremner WJ; Elliesen J; Gu YQ; Kersemaekers WM; McLachlan RI; Meriggiola MC; Nieschlag E; Sitruk-Ware R; Vogelsong K; Wang XH; Wu FC; Zitzmann M; Handelsman DJ; Wang C
J Clin Endocrinol Metab; 2008 May; 93(5):1774-83. PubMed ID: 18303073
[TBL] [Abstract][Full Text] [Related]
4. Baseline progestins characterization in surface waters of three main Portuguese estuaries.
Morais H; Cruzeiro C; Pardal MA; Cardoso PG
Mar Pollut Bull; 2023 Sep; 194(Pt B):115352. PubMed ID: 37573672
[TBL] [Abstract][Full Text] [Related]
5. Procoagulant effect of vitamin K antagonists?
Al Dieri R; Ten Cate-Hoek A; Bloemen S; Ten Cate H; Hemker HC
J Thromb Haemost; 2011 Dec; 9(12):2511-2. PubMed ID: 21981701
[No Abstract] [Full Text] [Related]
6. Dealing with the "T" (testosterone).
Mandell BF
Cleve Clin J Med; 2024 Feb; 91(2):78-79. PubMed ID: 38307603
[No Abstract] [Full Text] [Related]
7. Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception.
Pöllänen P; Nikkanen V; Huhtaniemi I
Int J Androl; 2001 Dec; 24(6):369-80. PubMed ID: 11737418
[TBL] [Abstract][Full Text] [Related]
8. Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development.
Amory JK; Anawalt BD; Bremner WJ; Matsumoto AM
J Androl; 2001; 22(6):1053-60. PubMed ID: 11700852
[TBL] [Abstract][Full Text] [Related]
9. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men.
von Eckardstein S; Noe G; Brache V; Nieschlag E; Croxatto H; Alvarez F; Moo-Young A; Sivin I; Kumar N; Small M; Sundaram K;
J Clin Endocrinol Metab; 2003 Nov; 88(11):5232-9. PubMed ID: 14602755
[TBL] [Abstract][Full Text] [Related]
10. Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception.
Anderson RA; Kinniburgh D; Baird DT
J Clin Endocrinol Metab; 2002 Aug; 87(8):3640-9. PubMed ID: 12161488
[TBL] [Abstract][Full Text] [Related]
11. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
[TBL] [Abstract][Full Text] [Related]
12. Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men.
Kinniburgh D; Zhu H; Cheng L; Kicman AT; Baird DT; Anderson RA
Hum Reprod; 2002 Jun; 17(6):1490-501. PubMed ID: 12042267
[TBL] [Abstract][Full Text] [Related]
13. Twenty-one day administration of dienogest reversibly suppresses gonadotropins and testosterone in normal men.
Meriggiola MC; Bremner WJ; Costantino A; Bertaccini A; Morselli-Labate AM; Huebler D; Kaufmann G; Oettel M; Flamigni C
J Clin Endocrinol Metab; 2002 May; 87(5):2107-13. PubMed ID: 11994349
[TBL] [Abstract][Full Text] [Related]
14. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism.
Wu FC; Balasubramanian R; Mulders TM; Coelingh-Bennink HJ
J Clin Endocrinol Metab; 1999 Jan; 84(1):112-22. PubMed ID: 9920070
[TBL] [Abstract][Full Text] [Related]
15. transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis.
Wang C; Cui YG; Wang XH; Jia Y; Sinha Hikim A; Lue YH; Tong JS; Qian LX; Sha JH; Zhou ZM; Hull L; Leung A; Swerdloff RS
J Clin Endocrinol Metab; 2007 Aug; 92(8):3292-304. PubMed ID: 17504903
[TBL] [Abstract][Full Text] [Related]
16. 7alpha-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men.
Walton MJ; Kumar N; Baird DT; Ludlow H; Anderson RA
J Androl; 2007; 28(5):679-88. PubMed ID: 17460095
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men.
Qoubaitary A; Meriggiola C; Ng CM; Lumbreras L; Cerpolini S; Pelusi G; Christensen PD; Hull L; Swerdloff RS; Wang C
J Androl; 2006; 27(6):853-67. PubMed ID: 16837736
[TBL] [Abstract][Full Text] [Related]
18. A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive.
Brady BM; Amory JK; Perheentupa A; Zitzmann M; Hay CJ; Apter D; Anderson RA; Bremner WJ; Pollanen P; Nieschlag E; Wu FC; Kersemaekers WM
Hum Reprod; 2006 Jan; 21(1):285-94. PubMed ID: 16172147
[TBL] [Abstract][Full Text] [Related]
19. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist.
Matthiesson KL; Amory JK; Berger R; Ugoni A; McLachlan RI; Bremner WJ
J Clin Endocrinol Metab; 2005 Jan; 90(1):91-7. PubMed ID: 15509637
[TBL] [Abstract][Full Text] [Related]
20. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen.
Coviello AD; Bremner WJ; Matsumoto AM; Herbst KL; Amory JK; Anawalt BD; Yan X; Brown TR; Wright WW; Zirkin BR; Jarow JP
J Androl; 2004; 25(6):931-8. PubMed ID: 15477366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
